Product Information
CHATEAL EQ-28 TABLET is a generic product labeled by Afaxys Pharma, LLC, priced at $0.1135 per EA under NDC 50102023023. Its NADAC has been published 412 times since Nov 14, 2018.
FDA first approved this application on Sep 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Afaxys Pharma, LLCNDC
50102023023
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA206866FDA Approved
9/23/2016
TE Code
AB
On Market Since
9/23/2016
Price Statistics
The NADAC for CHATEAL EQ-28 TABLET has been published 412 times since Nov 14, 2018, and over the history we have for it it has declined 51.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1135 per EA |
|---|---|
| All-time high | $0.3121 (Apr 15, 2020) |
| All-time low | $0.0800 (Nov 20, 2024) |
| 52-week high | $0.1210 |
| 52-week low | $0.1090 |
| Median price | $0.1641 |
| Average price | $0.1770 |
| Largest weekly change | +72.0% (Aug 21, 2024) |
| Weeks tracked | 412 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Afaxys Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHATEAL EQ-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHATEAL EQ-28 TABLET, manufactured by Afaxys Pharma, LLC, is $0.1135 per EA (NDC 50102023023), effective Sep 30, 2026.
How has the price of CHATEAL EQ-28 TABLET changed over time?
Over the history we have for it, the NADAC for CHATEAL EQ-28 TABLET has declined 51.0%. It has been tracked across 412 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for CHATEAL EQ-28 TABLET?
Since Nov 14, 2018, the NADAC for CHATEAL EQ-28 TABLET has ranged from a low of $0.0800 (Nov 20, 2024) to a high of $0.3121 (Apr 15, 2020), with a median of $0.1641 per EA.
Are there cheaper alternatives to CHATEAL EQ-28 TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CHATEAL EQ-28 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CHATEAL EQ-28 TABLET?
CHATEAL EQ-28 TABLET (NDC 50102023023) is labeled by Afaxys Pharma, LLC, and CMS classifies it as a generic product.